Tufts' poll probes social media in trials; Illumina talks genomics data bottlenecks;

> A Tufts survey found 20% of biopharma firms have contacted a patient directly on social media. Article

> Illumina's ($ILMN) president warned data management is an obstacle to genomics-powered improvements to cancer care. Piece

> Merge Healthcare ($MRGE) committed to creating a data center in Brazil after winning a contract with CRO Eurotrials. News

> Deloitte added the Regenstrief Institute to its real-world evidence and analytics consortium. Post

> Advanced Biological Laboratories started selling its genome data analysis tool, OncoChek. Release

> HCL Technologies renewed a contract with Purdue Pharma. Item